Improving Management of the Controlled Substances Quota Process

The hearing explores the findings and recommendations of a recent Government Accountability Office report which highlights challenges with the Drug Enforcement Administration and the Food and Drug Administration’s  management the Controlled Substances quota process. 

Senator Grassley's Statement | Senator Feinstein's Statement

Witnesses:

Marcia Crosse (Testimony)
Director of the Health Care Team at the U.S. Government Accountability Office (GAO), Washington, D.C.

Captain Valerie Jensen (Testimony)
Associate Director of the Drug Shortages Program at the Food and Drug Administration (FDA), Washington, D.C.

Joseph Rannazzisi (Testimony)
Deputy Assistant Administrator of Drug Diversion with the Drug Enforcement Administration (DEA), Washington, D.C.